NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
0.91
-0.16 (-14.95%)
At close: Aug 22, 2025, 3:59 PM
0.91
0.12%
After-hours: Aug 22, 2025, 07:56 PM EDT
NovaBay Pharmaceuticals Revenue
NovaBay Pharmaceuticals reported an annual revenue of $9.78M, reflecting a -6.45% growth. For the quarter ending June 30, 2025, NovaBay Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
9.78M
Revenue Growth
-6.45%
Price / Sales Ratio
0.21
Revenue / Employee
752.38K
Employees
13
Market Cap
5.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 9.78M | -6.45% |
| Dec 31, 2023 | 10.46M | -27.42% |
| Dec 31, 2022 | 14.4M | +71.05% |
| Dec 31, 2021 | 8.42M | -15.23% |
| Dec 31, 2020 | 9.93M | +50.54% |
| Dec 31, 2019 | 6.6M | -47.24% |
| Dec 31, 2018 | 12.51M | -31.39% |
| Dec 31, 2017 | 18.23M | +53.23% |
| Dec 31, 2016 | 11.9M | +171.56% |
| Dec 31, 2015 | 4.38M | +315.65% |
| Dec 31, 2014 | 1.05M | -69.69% |
| Dec 31, 2013 | 3.48M | -49.95% |
| Dec 31, 2012 | 6.95M | -36.95% |
| Dec 31, 2011 | 11.02M | +12.97% |
| Dec 31, 2010 | 9.75M | -37.81% |
| Dec 31, 2009 | 15.68M | +133.32% |
| Dec 31, 2008 | 6.72M | +13.68% |
| Dec 31, 2007 | 5.91M | +285.71% |
| Dec 31, 2006 | 1.53M | +Infinity% |
| Dec 31, 2005 | 0 | n/a |
| Dec 31, 2004 | 0 | n/a |
| Dec 31, 2003 | 0 | n/a |